Invitation: Press Trip for Science Journalists to Baden-Württemberg/Germany on « Renewable Energies »

Invitation: Press Trip « Renewable Energies in Baden-Württemberg »/Germany

Baden-Württemberg International invites selected science journalists from different countries to a press trip to the federal state of Baden-Württemberg in Germany from 5th to 8th of October 2015. The main content of the press trip will be the topic “Renewable Energies in Baden-Württemberg”. The programme includes visits and specialist meetings with selected universities, research institutions, companies and political institutions. The deadline for application is 6 September 2015.

HITS Journalist in Residence is Open Now. Deadline to Apply 15 September 2015!

A unique opportunity for experienced journalists interested in science, mathematics, and computer science

The Heidelberg Institute for Theoretical Studies (HITS) is a basic research institute promoting data-driven science. 120 scientists from 22 countries are working in research fields from molecular biology to astrophysics – working with mathematical methods and computer science tools. 

HITS has started the “Journalist in Residence” program 4 years ago. It offers a paid 3-6 months´stay (5000 Euros per month) for experienced science journalists interested in Big Data. Up to now, four journalists from the U.S., Spain, and Germany have been at HITS.READ MORE

Launch Of New Resource On Hepatitis C for Journalists Worldwide

A World Federation of Science Journalists Global Media Education Initiative

PRESS RELEASE: The WFSJ is launching a new initiative to help journalists report on the staggering toll of Hepatitis C (HCV) as well as the scientific and political barriers to treating the disease.

To be launched on World Hepatitis Day (July 28, 2015), the new website presents resources written by journalists for journalists to expose the complex issues preventing effective prevention and treatment of the disease as well as a database of HCV experts from around the world who can be interviewed on a range of issues– from physician/scientists and patient groups, to public policy experts.